top of page

Team Members

Dr. Peter-Leon Hagedoorn

Dr. Peter-Leon Hagedoorn

Coordinator, TU Delft

Peter-Leon Hagedoorn is an expert in the mechanistic investigation of metalloenzymes such as ferritin and chlorite dismutase, and he pioneered a new approach for metalloproteomics, called MIRAGE.

Prof. dr. Sarel Fleishman

Prof. dr. Sarel Fleishman

Weizmann institute

We probe our understanding of protein design principles by designing new proteins and testing their activities in the lab.

Dr. Javier Vina

Dr. Javier Vina

EvoEnzyme

EvoEnzyme designs customized biocatalysts through directed evolution.

Prof. dr hab. Maciej Szaleniec

Prof. dr hab. Maciej Szaleniec

IKIFP

Our research focuses on various bacterial enzymes catalyzing the regioselective and enantioselective synthesis of alcohols, dehydrogenation of steroids, oxidation of aldehydes/ reduction of carboxylic acids and radical C-C bond formation.

Deborah Boes

Deborah Boes

TU Delft

Expressing tungsten enzymes in E. coli for large-scale production, tackling biosynthesis bottlenecks.

Natalia Dyachenko

Natalia Dyachenko

University of Oxford

​

Anna Demitraszek

Anna Demitraszek

IKIFP

​

Prof. dr. Frank Hollmann

Prof. dr. Frank Hollmann

TU Delft

Our research interest focus around the application of oxidoreductases for organic synthesis.

Dr. Claudia Andreini

Dr. Claudia Andreini

University of Florence

We pioneered the use of bioinformatics to study metalloproteins.

Dr. Ivan Mateljak

Dr. Ivan Mateljak

Evoenzyme

EvoEnzyme designs customized biocatalysts through directed evolution.

Dr. Yutong Wang

Dr. Yutong Wang

TU Delft

​

Dr. Richard Mclean

Dr. Richard Mclean

Weizmann institute

Improving the expressibility of the Pyrococcus furiosus Wco biosynthetic pathway in E. coli

Dr. Marta Olszak-Płachta

Dr. Marta Olszak-Płachta

IKIFP

​

Victor Baerle

Victor Baerle

IKIFP

​

Dr. Caroline Paul

Dr. Caroline Paul

TU Delft

The current main research interests of the Paul group are towards exploring the synthetic potential of Nature's catalysts.

Prof. dr. Kylie Vincent

Prof. dr. Kylie Vincent

University of Oxford

Interested in more sustainable ways of driving biocatalysis, replacing carbon-based reductants with hydrogen gas.

Dr. Holly Reeve

Dr. Holly Reeve

HydRegen

Biotechnology for cleaner, safer and more sustainable chemical manufacture.

Alice Pedroni

Alice Pedroni

TU Delft

Enzymes production, purification and activity characterisation.

Tomasso Attucci

Tomasso Attucci

University of Florence

​

Dr. Patrycja Wójcik

Dr. Patrycja Wójcik

IKIFP

​

International Advisory Board

ChainCraft logo payoff RGB.jpg

ChainCraft is a leading scale-up company in the production and marketing of sustainable medium chain fatty acids. These fatty acids are produced from organic waste via a proprietary fermentation process and can be used in existing and new applications in a.o. animal feed, lubricants, plasticizers, herbicides and flavours and fragrances. The main products are the C4, C5 and C6 fatty acids (butyric, valeric and caproic acid). Since 2019 a commercial demonstration plant is operational which has an annual production capacity of up to 2.000 tonnes of fatty acids. ChainCraft is honoured to be a part of the Industrial Advisory Board of W-BioCat and is excited for the development of enzymes capable to produce aldehydes or alcohols for our sustainable fatty acids.

​

ChainCraft - Turning chemistry circular

Axxence logo.png

Axxence Aromatic was founded in 1986 and is a privately held company.  Over the years it has maintained its focus: entire dedication to be one of the most reliable and innovative sources within our prime field of expertise:  NATURAL AROMA INGREDIENTS for the flavour & fragrance compounding industry worldwide. By strategic investments in R&D of both novel natural ingredients and new manufacturing processes,  we constantly strive to expand the use of our products in existing and new applications as well as markets.

Sales offices and warehousing are in Germany, France, USA and Japan. In China we operate a technical support facility.

​

Duft Parfüms Duftststoffe Geschmack Aromen | Axxence Aromatic GmbH

Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €18.5 billion and an operating profit (adjusted EBITDA) of €2.49 billion in 2022. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. About 34,000 employees work together for a common purpose: We want to improve life today and tomorrow.

​

One of the world leaders in Specialty Chemicals - Evonik Industries

Coordinator

Peter-Leon Hagedoorn

Department of Biotechnology
Delft University of Technology

W-BioCat logo

Van der Maasweg 9

2629HZ Delft, The Netherlands

+31 15 2782334

  • Linkedin

Thanks for submitting!

©2023 by Peter-Leon Hagedoorn

bottom of page